Table 1.
Curative group | Palliative group | All | |
n | 7 | 6 | 13 |
Median age (range) (yr) | 66 (32-87) | 57 (42-78) | 66 (32-87) |
Gender (M/F) | 2/5 | 1/5 | 3/10 |
Presenting symptoms n (%) | |||
Abdominal pain | 1 | 4 | 5 (38.5) |
Intra-abdominal mass | 4 | 0 | 4 (30.8) |
Obstructive jaundice | 0 | 1 | 2 (15.4) |
Small bowel obstruction | 0 | 1 | 1 (7.7) |
Bowel habit change | 1 | 0 | 1 (7.7) |
Tenesmus | 1 | 0 | 1 (7.7) |
Investigation n (%) | |||
Abdominal CT | 5 | 3 | 8 (61.5) |
Endoscopy | 1 | 1 | 2 (15.1) |
Upper GI study | 0 | 1 | 1 (7.7) |
Barium enema | 1 | 0 | 1 (7.7) |
Origin of GI MM n (%) | |||
Primary | 7 | 0 | 7 (53.8) |
Secondary | 0 | 3 | 3 (23.1) |
Unknown primary | 0 | 3 | 3 (23.1) |
Site of the tumor n (%) | |||
Anorectal | 5 | 2 | 7 (53.8) |
Stomach | 1 | 2 | 3 (23.1) |
Jejunum | 0 | 1 | 1 (7.7) |
Pancreas | 0 | 1 | 1 (7.7) |
Sigmoid colon | 1 | 0 | 1 (7.7) |
Survival times (mo) | |||
Mean | 29.7 | 4.8 | 17 |
Range | 10-96 | 4-12 | 4-96 |
MM: Malignant melanoma; GI: Gastrointestinal; CT: Computed tomography.